Valuation: Stryker Corporation

Market Cap 127B 659B 110B 103B 93.85B 176B 12,164B 179B 1,208B 473B 6,094B 478B 467B 20,272B P/E 2026 *
25.8x
P/E 2027 * 22.4x
Enterprise Value 136B 707B 118B 110B 101B 189B 13,037B 192B 1,295B 507B 6,531B 512B 501B 21,726B EV / Sales 2026 *
5x
EV / Sales 2027 * 4.48x
Free-Float
94.9%
Yield 2026 *
1.09%
Yield 2027 * 1.16%
1 day-1.49%
1 week+1.22%
Current month+0.70%
1 month+11.62%
3 months+14.11%
6 months-5.04%
Current year-10.09%
1 week 88.62
Extreme 88.62
88.74
1 month 78.55
Extreme 78.55
90.08
Current year 69.77
Extreme 69.77
99.8
1 year 69.77
Extreme 69.77
107.34
3 years 64.71
Extreme 64.71
120.24
5 years 50.67
Extreme 50.666
120.24
10 years 44.61
Extreme 44.61
120.24
Manager TitleAgeSince
Chief Executive Officer 60 2012-09-30
Director of Finance/CFO 50 2025-03-31
President 49 2025-12-31
Director TitleAgeSince
Director/Board Member 82 1973-12-31
Director/Board Member 71 1983-12-31
Chairman 60 2014-07-21
Change 5-day change 1-year change 3-year change Capi.($)
-1.49%+1.22% - - 130B
-2.22%-4.09%-13.15%+19.34% 130B
-0.73%-1.58%-19.14%+0.51% 12.49B
+0.59%+2.32%+106.57%+157.41% 10.88B
-1.32%-5.77%-45.30%-68.20% 4.51B
-2.01%-0.57%-25.77%+42.51% 2.72B
-0.05%-2.43%-21.35%-13.61% 1.66B
-1.56%-2.27%-34.51%-36.28% 1.66B
+0.21%-4.19%-34.81%-72.87% 1.65B
Average -0.95%-2.13%-10.93%+3.60% 20.71B
Weighted average by Cap. -1.69%-3.39%-7.34%+23.18%

Financials

2026 *2027 *
Net sales 27.29B 141B 23.56B 22.1B 20.13B 37.86B 2,609B 38.38B 259B 102B 1,307B 102B 100B 4,349B 29.68B 154B 25.62B 24.04B 21.9B 41.17B 2,838B 41.74B 282B 110B 1,422B 111B 109B 4,730B
Net income 4.94B 25.61B 4.27B 4B 3.65B 6.85B 472B 6.95B 46.92B 18.39B 237B 18.55B 18.15B 787B 5.75B 29.78B 4.96B 4.65B 4.24B 7.97B 549B 8.08B 54.56B 21.38B 275B 21.57B 21.11B 916B
Net Debt 9.13B 47.3B 7.88B 7.39B 6.73B 12.66B 872B 12.83B 86.64B 33.95B 437B 34.26B 33.52B 1,454B 5.89B 30.52B 5.08B 4.77B 4.34B 8.17B 563B 8.28B 55.9B 21.91B 282B 22.11B 21.63B 938B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
26-08-13 R$88.74 -1.49% 34
26-08-11 R$90.08 +2.75% 42
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
331.68USD
Average target price
382.88USD
Spread / Average Target
+15.44%

Quarterly revenue - Rate of surprise